Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice
Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · +2 more institutions
Abstract
Recent evidence indicates that the gut microbiota plays a key role in the pathophysiology of obesity. Indeed, diet-induced obesity (DIO) has been associated to substantial changes in gut microbiota composition in rodent models. In the context of obesity, enhanced adiposity is accompanied by low-grade inflammation of this tissue but the exact link with gut microbial community remains unknown. In this report, we studied the consequences of high-fat diet (HFD) administration on metabolic parameters and gut microbiota composition over different periods of time. We found that Akkermansia muciniphila abundance was strongly and negatively affected by age and HFD feeding and to a lower extend Bilophila wadsworthia was…
Citation impact
- FWCI
- 27.71
- Percentile
- 100%
- References
- 43
Authors
9- MSMarc SchneebergerCorresponding
Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona
- AEAmandine Everard
Walloon Excellence in Lifesciences and Biotechnology
- AGAlícia G. Gómez-Valadés
Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
- SMSébastien Matamoros
Walloon Excellence in Lifesciences and Biotechnology
- SRSara Ramírez
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
Topics & keywords
- Akkermansia muciniphila
- Gut flora
- Akkermansia
- Adipose tissue
- Biology
- Endocrinology
- Internal medicine
- Inflammation
Funding
- ECEuropean CommissionAwards: 267248, 336452
- FDFonds De La Recherche Scientifique - FNRSAwards: 12/17-047, WELBIO-CR-2012S-02R, T.0138.14, 3.4579.11
- GDGeneralitat de CatalunyaAward: 2014 SGR 659
- FWFédération Wallonie-Bruxelles
- MDMinisterio de Ciencia e Innovación
- WEWalloon excellence in life sciences and biotechnology
- IDInstituto de Salud Carlos IIIAwards: PI13/01500, PI13/01604
- EREuropean Regional Development Fund